经常出现的棕色瘤作为一次性甲状腺功能障碍症的表现性投诉:一个病例报告
Muhammad Saad1, Muhammad Rayan Syed1, Ifrah Hamza2
1Liaquat University of Medical and Health Sciences Jamshoro Pakistan.
Clinical case reports
|July 16, 2025
概括
棕色瘤,罕见的骨病变是由甲状腺功能障碍症引起的,可以在部表现出来. 手术干预和副甲状腺切除术在一个36岁的女性患者中解决了这种情况.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 口腔和牙面部外科手术
背景情况:
- 棕色瘤是甲状腺功能障碍症的罕见表现,是由于异常的骨重塑造成的.
- 虽然它们通常会影响长骨,骨盆和肋骨,但它们可以发生在任何骨头,包括下巴.
- 在临床实践中,早期检测甲状腺功能障碍症已经减少了棕色瘤的发生率.
研究的目的:
- 报告一个棕色瘤的情况在下和大二次的甲状腺功能障碍.
- 强调在口腔群体的差异诊断中考虑棕色瘤的重要性.
- 为了说明通过副甲状腺切除术成功治疗棕色瘤.
主要方法:
- 一个36岁的女性病例研究,患有反复出现的口腔胀.
- 诊断程序包括切口活检和实验室检查甲状腺功能障碍症.
- 手术管理涉及副甲状腺腺瘤的副甲状腺切除术.
主要成果:
- 患者呈现出右下和左上区域的胀.
- 活检和实验室结果证实棕色瘤是偏甲状腺功能障碍症的次要原因.
- 副甲状腺切除术后的术后恢复没有任何事件.
结论:
- 棕色瘤虽然很少见,但仍然是骨瘤和口腔质量的显著差异诊断.
- 在无法解释的骨损伤的情况下,特别是在大面部区域,应考虑甲状腺功能增强症.
- 副甲状腺切除术是对由副甲状腺腺瘤引起的棕色瘤的有效治疗方法.
相关概念视频
The Parathyroid Glands
5.2K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
5.2K
Hyperthyroidism I: Introduction
59
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
59
Hyperthyroidism II: Pathophysiology
36
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36
Graves' Disease I: Introduction
49
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
49
Graves Disease II: Pathophysiology
33
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
33
Hypothyroidism II: Pathophysiology
35
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
35


